Literature DB >> 9444946

Effects of transfection of p210bcr-abl and bcr-v-abl into the factor-dependent human leukemia cell line HSM-911.

M Takahashi1, N Shigeno, H Takahashi, N Suzuki, M Masuko, K Nikkuni, K Toba, T Furukawa, S Aoki, K Kishi, T Koike, Y Aizawa.   

Abstract

In order to clarify the action of the bcr-abl, a growth factor dependent human leukemic cell line (HSM-911) was transfected with p210bcr-abl or bcr-v-abl by electroporation. The cells transfected with bcr-v-abl, but not the cells transfected with p210bcr-abl, became growth factor independent. Some clones of the cells transfected with p210bcr-abl demonstrated cellular maturation (nuclear segmentation, becoming positive for naphthol ASD chloroacetate esterase, the disappearance of CD34 expression and the appearance of glycophorin A and CD10 expression). Moreover, these clones transfected with p210bcr-abl demonstrated apoptosis (increased expression of Fas and DNA ladder formation suggesting apoptotic DNA fragmentation). These findings demonstrated the different actions of p210 bcr-abl and bcr-v-abl, the former of which gave the cells the characteristics of maturation like the cells from chronic myelogenous leukemia, and the latter of which rendered the cells grow autonomously.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9444946     DOI: 10.1016/s0145-2126(97)00096-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  2 in total

1.  Cytoplasmic expression of EGFP in dendritic cells transfected with in vitro transcribed mRNA or cellular total RNA extracted from EGFP expressing leukemia cells.

Authors:  Masuhiro Takahashi; Miwako Narita; Flavio Ayres; Naoko Satoh; Takashi Abe; Toshio Yanao; Tatsuo Furukawa; Ken Toba; Takeshi Hirohashi; Yoshifusa Aizawa
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

2.  Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene.

Authors:  Minami Iwabuchi; Miwako Narita; Takayoshi Uchiyama; Shunpei Iwaya; Eri Oiwa; Yoshinori Nishizawa; Shigeo Hashimoto; Aude Bonehill; Noriyuki Kasahara; Jun Takizawa; Masuhiro Takahashi
Journal:  Mol Med Rep       Date:  2015-04-24       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.